Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

Vitamin B6 metabolism influences the intracellular accumulation of cisplatin

(2013) Lorenzo Galluzzi et al.   CELL CYCLE

Cisplatin-induced apoptosis and development of resistance are transcriptionally distinct processes

(2012) Theocharis Panaretakis   CELL CYCLE

Transcriptional profiling of apoptosis

(2012) Zhi Yao et al.   CELL CYCLE

Independent transcriptional reprogramming and apoptosis induction by cisplatin

(2012) Lorenzo Galluzzi et al.   CELL CYCLE

Enhancement of Synthetic Lethality via Combinations of ABT-888, a PARP Inhibitor, and Carboplatin In Vitro and In Vivo Using BRCA1 and BRCA2 Isogenic Models

(2012) C. C. Clark et al.   MOLECULAR CANCER THERAPEUTICS

The potential of exploiting DNA-repair defects for optimizing lung cancer treatment

(2012) Sophie Postel-Vinay et al.   Nature Reviews Clinical Oncology

New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

(2012) Bryan A. Gibson et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

(2012) Jonathan Ledermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

(2012) Lorenzo Galluzzi et al.   Cell Reports

How do real tumors become resistant to cisplatin?

(2011) Piet Borst et al.   CELL CYCLE

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

(2011) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

Cell death assays for drug discovery

(2011) Oliver Kepp et al.   NATURE REVIEWS DRUG DISCOVERY

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

(2010) Hanna Berglind et al.   CANCER BIOLOGY & THERAPY

Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer

(2010) C. M. Annunziata et al.   CLINICAL CANCER RESEARCH

Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos

(2010) Ilio Vitale et al.   EMBO JOURNAL

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

(2010) M William Audeh et al.   LANCET

Expanding the horizons of PARP inhibitors

(2010) Teresa Villanueva   NATURE REVIEWS DRUG DISCOVERY

Testicular germ cell tumors: pathogenesis, diagnosis and treatment

(2010) Christian Winter et al.   Nature Reviews Endocrinology

Molecular mechanisms of necroptosis: an ordered cellular explosion

(2010) Peter Vandenabeele et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

A flexible unified approach to the analysis of pre-clinical combination studies

(2010) Chris Harbron   STATISTICS IN MEDICINE

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

(2009) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

(2008) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute